NCT03627091 Efficacy and Safety Study of Ontamalimab as Maintenance Treatment in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 307) Status TERMINATED Phase PHASE3
NCT03599622 An Investigational Study of Experimental Medication BMS-986165 in Participants With Moderate to Severe Crohn's Disease Status TERMINATED Phase PHASE2
NCT03566823 Efficacy and Safety Study of Ontamalimab as Induction Therapy in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 306) Status TERMINATED Phase PHASE3
NCT03566407 Blood and Stool Molecular Biomarkers Longitudinal Detection Study in Crohn's Disease (CD) Patients Status TERMINATED Phase NA
NCT03559660 CUP Certolizumab Pegol (CDP-870) in Adults Suffering From Crohn's Disease (CD) Status NO_LONGER_AVAILABLE Phase N/A
NCT03559517 Efficacy and Safety Study of Ontamalimab as Induction Therapy in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 305) Status TERMINATED Phase PHASE3
NCT03478956 A Phase I Study of Etrolizumab Followed by Open-Label Extension and Safety Monitoring in Pediatric Patients With Moderate to Severe Ulcerative Colitis or Moderate to Severe Crohn's Disease Status TERMINATED Phase PHASE1
NCT03466411 A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease Status ACTIVE_NOT_RECRUITING Phase PHASE2/PHASE3
NCT03404557 Proteomic Analysis of Crohn's Disease Macrophages in Response or Not to AIEC Status COMPLETED Phase N/A
NCT03397108 Assessing the Drug Exposure Risk of Infants Breastfed by Women With Inflammatory Bowel Disease Status COMPLETED Phase N/A
NCT03395184 Study To Evaluate The Efficacy And Safety Of Oral PF-06651600 And PF-06700841 In Subjects With Moderate To Severe Crohn's Disease Status COMPLETED Phase PHASE2
NCT03345849 A Study of the Efficacy and Safety of Upadacitinib in Participants With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Conventional and/or Biologic Therapies Status COMPLETED Phase PHASE3
NCT03345836 A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Biologic Therapy Status COMPLETED Phase PHASE3
NCT03345823 A Maintenance and Long-Term Extension Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Crohn's Disease Who Completed the Studies M14-431 or M14-433 Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT03283085 A Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA) Status COMPLETED Phase PHASE3
NCT03279081 Study to Assess Efficacy and Safety of Cx601, Adult Allogeneic Expanded Adipose-derived Stem Cells (eASC) for the Treatment of Complex Perianal Fistula(s) in Participants With Crohn's Disease (CD) Status COMPLETED Phase PHASE3
NCT03257345 VEST: The UK Vedolizumab Real Life Experience Study in Inflammatory Bowel Disease Status UNKNOWN Phase N/A
NCT03256240 Study of the Kono-S Anastomosis Versus the Side-to-side Functional End Anastomosis Status RECRUITING Phase NA